Identification of transcription factors and coactivators affected by dibutylphthalate interactions in fetal rat

Simon M Plummer1, Dhritiman Dan, Joanne Quinney

  • 1CXR Biosciences Ltd, Dundee DD1 5JJ, UK. simonplummer@micromatrices.com

Insights

Dibutylphthalate (DBP) exposure in fetal rats disrupts steroidogenesis by inhibiting steroidogenic factor 1 (SF1) binding and increasing peroxisome proliferator-activated receptor alpha (PPARα) binding to key genes. This suggests PPARα acts as a transrepressor, contributing to testicular maldevelopment.

Area of Science:

  • Endocrinology
  • Toxicology
  • Molecular Biology

Background:

  • In utero exposure to dibutylphthalate (DBP) causes antiandrogenic effects in fetal rat testes.
  • Previous studies suggest DBP's effects involve indirect inhibition of steroidogenic factor 1 (SF1).
  • Peroxisome proliferator-activated receptor alpha (PPARα) involvement via coactivator sequestration was hypothesized.

Purpose of the Study:

  • To investigate the role of PPARα in DBP-induced testicular maldevelopment.
  • To assess the DNA binding of PPARα, SF1, CBP, and RNA polymerase II in DBP-exposed fetal rat testes.
  • To determine if DBP alters SF1 and PPARα binding to steroidogenic genes.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) microarray analysis was performed on fetal rat testes.
  • Gene expression data from gestational days 15, 17, and 19 were analyzed.
  • Specific gene targets including CYP11a, StAR, CYP17a, and FSHR were examined for protein binding.

Main Results:

  • DBP treatment reduced SF1 binding to CYP11a, StAR, and CYP17a genes.
  • DBP treatment increased PPARα binding to regulatory regions of CYP11a, StAR, and CYP17a.
  • PPARα binding was not detected in the FSHR promoter, which was unaffected by DBP.

Conclusions:

  • DBP-induced repression of SF1-regulated steroidogenic genes correlates with reduced SF1 DNA binding and increased PPARα DNA binding.
  • PPARα may function as an indirect transrepressor of SF1 on steroidogenic genes in response to DBP.
  • These findings elucidate a mechanism for DBP's antiandrogenic effects during testicular development.